VTGN vs XBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

VTGN

52.6
AI Score
VS
XBIO Wins

XBIO

53.1
AI Score

Investment Advisor Scores

VTGN

53score
Recommendation
HOLD

XBIO

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric VTGN XBIO Winner
Revenue 354,000 1.47M XBIO
Net Income -7.75M -1.39M XBIO
Net Margin -2187.9% -94.5% XBIO
Operating Income -7.75M -1.47M XBIO
ROE -9.0% -22.8% VTGN
ROA -7.5% -19.9% VTGN
Total Assets 103.91M 6.97M VTGN
Current Ratio 15.93 7.43 VTGN

Relative Price Performance (Last 90 Days)

VTGN 1M: -39.1% · 3M: -21.9% XBIO 1M: -30.4% · 3M: -31.2%

Current Technical Phase

VTGN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.5%), weak momentum, RSI 32

RSI (14): 31.9 · Price: $0.18

XBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.6%), weak momentum, RSI 28

RSI (14): 27.7 · Price: $1.72

Fundamentals Snapshot

Metric VTGN XBIO
Market Cap — —
Forward P/E -0.2 -5.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 5.0% 0.1%
Gross Margin 1.0% 1.0%
Operating Margin -9.0% -1.5%
EPS -1.66 -1.09
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, XBIO is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.